These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


400 related items for PubMed ID: 21417967

  • 1. The role of selective neck dissection in pathological N1 squamous cell carcinomas of the head and neck.
    Yıldırım T, Ozmen OA, Erişen L, Kasapoğlu F, Coşkun H, Basut O, Onart S, Hızalan I.
    Kulak Burun Bogaz Ihtis Derg; 2011; 21(2):63-9. PubMed ID: 21417967
    [Abstract] [Full Text] [Related]

  • 2. Preservation of function by radiotherapy of small primary carcinomas preceded by neck dissection for extensive nodal metastases of the head and neck.
    Verschuur HP, Keus RB, Hilgers FJ, Balm AJ, Gregor RT.
    Head Neck; 1996; 18(3):277-82. PubMed ID: 8860770
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Lohuis PJ, Klop WM, Tan IB, van Den Brekel MW, Hilgers FJ, Balm AJ.
    Am J Surg; 2004 Feb; 187(2):295-9. PubMed ID: 14769324
    [Abstract] [Full Text] [Related]

  • 4. Elective neck dissection vs observation in transorally treated early head and neck carcinomas with cN0 neck.
    Psychogios G, Mantsopoulos K, Koch M, Klintworth N, Kapsreiter M, Zenk J, Iro H.
    Acta Otolaryngol; 2013 Mar; 133(3):313-7. PubMed ID: 23294240
    [Abstract] [Full Text] [Related]

  • 5. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
    Wong LY, Wei WI, Lam LK, Yuen AP.
    Head Neck; 2003 Nov; 25(11):953-9. PubMed ID: 14603456
    [Abstract] [Full Text] [Related]

  • 6. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB, Cernea CR, Inoue M, Ferraz AR.
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [Abstract] [Full Text] [Related]

  • 7. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK, Sessions DG, Lenox J.
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
    Pradier O, Christiansen H, Schmidberger H, Martin A, Jäckel MC, Steiner W, Ambrosch P, Kahler E, Hess CF.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1368-77. PubMed ID: 16169679
    [Abstract] [Full Text] [Related]

  • 10. [Results of transoral laser resection in T1-2 oropharyngeal, hypopharyngeal and laryngeal carcinomas].
    Iro H, Mantsopoulos K, Zenk J, Waldfahrer F, Psychogios G.
    Laryngorhinootologie; 2011 Aug 01; 90(8):481-5. PubMed ID: 21850614
    [Abstract] [Full Text] [Related]

  • 11. Internal jugular vein preservation in neck dissection for pN1-N2c oral and oropharyngeal carcinoma.
    Pontes E, Filho JG, Agra IM, Carvalho AL, Magrin J, Kowalski LP.
    Am J Otolaryngol; 2007 Aug 01; 28(5):316-20. PubMed ID: 17826532
    [Abstract] [Full Text] [Related]

  • 12. [Selective neck dissection for node-positive necks (N1, N2) in patients with head and neck squamous cell carcinoma].
    Tao Y, Liu YH, Yu CX, Li HW, Zang Y.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep 01; 43(9):681-5. PubMed ID: 19035262
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of modified radical neck dissection and postoperative radiotherapy.
    Zwetyenga N, Fricain JC, Demeaux H, Deminière C, Siberchicot F.
    Rev Stomatol Chir Maxillofac; 2010 Apr 01; 111(2):59-62. PubMed ID: 20207384
    [Abstract] [Full Text] [Related]

  • 14. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P, Valavaara R, Aitasalo K, Kulmala J, Laine J, Elomaa L, Sillanmäki L, Minn H, Grénman R.
    Radiother Oncol; 2006 Feb 01; 78(2):146-51. PubMed ID: 16307813
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?
    Lim YC, Lee JS, Choi EC.
    Acta Otolaryngol; 2009 Jan 01; 129(1):57-61. PubMed ID: 18607981
    [Abstract] [Full Text] [Related]

  • 16. Factors predictive of successful outcome following salvage treatment of isolated neck recurrences.
    Lim JY, Lim YC, Kim SH, Byeon HK, Choi EC.
    Otolaryngol Head Neck Surg; 2010 Jun 01; 142(6):832-7. PubMed ID: 20493354
    [Abstract] [Full Text] [Related]

  • 17. Selective neck dissection is effective in N1/N2 nodal stage oral cavity squamous cell carcinoma.
    Battoo AJ, Hedne N, Ahmad SZ, Thankappan K, Iyer S, Kuriakose MA.
    J Oral Maxillofac Surg; 2013 Mar 01; 71(3):636-43. PubMed ID: 22884115
    [Abstract] [Full Text] [Related]

  • 18. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
    Iype EM, Sebastian P, Mathew A, Balagopal PG, Varghese BT, Thomas S.
    Oral Oncol; 2008 Dec 01; 44(12):1134-8. PubMed ID: 18486527
    [Abstract] [Full Text] [Related]

  • 19. Modified neck dissection. A study of 967 cases from 1970 to 1980.
    Byers RM.
    Am J Surg; 1985 Oct 01; 150(4):414-21. PubMed ID: 4051103
    [Abstract] [Full Text] [Related]

  • 20. Neck recurrence after level I-IV or I-III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma.
    Bajwa MS, McMillan R, Khattak O, Thomas M, Krishnan OP, Webster K.
    Head Neck; 2011 Mar 01; 33(3):403-6. PubMed ID: 20629073
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.